However FAS is resistant to many cancer medicines .
This effect of orlistat as a FAS - inhibitor was first identified in a high throughput screening for enzymes with prostate cancer inhibition activity .
FAS is resistant to many cancer medicines .
This effect of orlistat as a FAS - inhibitor was first identified in a high throughput screening for enzymes with prostate cancer inhibition activity .